DERM
DERM
NASDAQ · Pharmaceuticals

Journey Medical Corp

$5.07
+0.07 (+1.40%)
As of May 9, 9:41 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +208.9% upside
Low Target $10.95
Average Target $15.66
High Target $21.05
Current Price $5.07
Current
$5.07
Target
$15.66
$10.95 $15.66 avg $21.05
Scenario Analysis
Bear Case
$10.95
116.0%
Low target
Base Case
$15.66
+208.9%
Avg target
Bull Case
$21.05
+315.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$9.56
-46.9% from high
52-Week Low
$4.31
+17.6% from low
Target vs 52W High
$15.66
+63.9% vs high
Next Earnings Report
May 13, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.08
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%